Sleep Quality and Disease Severity in Patients With Chronic Rhinosinusitis.

Sleep quality and disease severity in patients with chronic rhinosinusitis.

Laryngoscope. 2013 Aug 5;
Alt JA, Smith TL, Mace JC, Soler ZM

To evaluate sleep quality in patients with chronic rhinosinusitis (CRS) using a validated outcome measure and to compare measures of CRS disease severity with sleep dysfunction.Cross-sectional evaluation of a multi-center cohort.According to the 2007 Adult Sinusitis Guidelines, patients with CRS were prospectively enrolled from four academic, tertiary care centers across North America. Each subject completed the Pittsburgh Sleep Quality Index (PSQI) instrument, in addition to CRS-specific measures of quality-of-life (QOL), endoscopy, computed tomography (CT), and olfaction. Patient demographics, comorbid conditions, and clinical measures of disease severity were compared between patients with “good” (PSQI; ?5) and “poor” (PSQI;?>?5) sleep quality.Patients (n?=?268) reported a mean PSQI score of 9.4 (range: 0-21). Seventy-five percent of patients reported PSQI scores above the traditional cutoff, indicating poor sleep quality. Patients with poor sleep quality were found to have significantly worse QOL scores on both the Rhinosinusitis Disability Index (P?HubMed – depression

Pain over time and its effects on life in thalassemia.

Am J Hematol. 2013 Aug 5;
Oliveros O, Trachtenberg F, Haines D, Gerstenberger E, Martin M, Carson S, Green S, Calamaras D, Hess P, Yamashita R, Vichinsky E,

Pain reports have become increasingly common and problematic in thalassemia. As patients are living longer, there is a growing need to study pain and explore its impact on patient lives. The Brief Pain Inventory (BPI) was used quarterly to assess pain and pain interference in North American thalassemia patients. The SF-36 and HADS were used to assess quality of life, anxiety, and depression. Of the 252 participants, 56% reported pain at least once over the course of this study, with 32% reporting severe pain (?7/10); 16% reported pain at all 4 visits. Increased pain severity significantly interfered with daily life (p<0.001; regression analysis), and participants with more sites of pain showed an increase in the amount of daily activities affected by pain (p=0.001). Participants reporting more visits with pain reported a significantly higher impact on affective and physical function (p <0.001). Physical quality of life decreased with increasing numbers of visits with pain (p <0.001). Those who reported one or more sites of pain showed increased symptoms of both depression (p <0.001) and anxiety (p= 0.003). Participants reporting at least two visits with pain had higher symptoms of anxiety (p= 0.002), and those with at least three visits, higher symptoms of depression (p= 0.003). Pain in thalassemia is a common, often chronic condition that interferes with life. The study highlights the significance of pain in thalassemia and its impact should be considered in future research and treatments. HubMed – depression

Postpartum Depression in Mothers of Infants in Neonatal Intensive Care Unit: Risk Factors and Management Strategies.

Am J Perinatol. 2013 Aug 5;
Vasa R, Eldeirawi K, Kuriakose VG, Nair G J, Newsom C, Bates J

Objective The aim of this study is to assess incidence, risk factors, and management strategies for Postpartum depression (PPD) in mothers of neonatal intensive care unit (NICU) infants.Study Design A total of 131 mothers completed the study assessment tool (Edinburgh Postnatal Depression Scale with additional questions). Score of 10 or above was considered to indicate risk for PPD (subclinical depression). Risk factors were examined with particular emphasis on length of stay (LOS).Results Approximately 19.1% of mothers experienced (subclinical) PPD. Depression during current and previous pregnancy, and problems with current delivery were strong predicting risk factors for PPD. As the LOS increased beyond 2 weeks, the odds of PPD risks initially increased, then leveled off, and then decreased after 31 days.Conclusion We recommend that the mothers of NICU infants be routinely screened for PPD and aggressively treated. HubMed – depression

The impact of comorbidity on Health-Related Quality of Life among cancer survivors: analyses of data from the PROFILES registry.

J Cancer Surviv. 2013 Aug 6;
Vissers PA, Thong MS, Pouwer F, Zanders MM, Coebergh JW, van de Poll-Franse LV

The aim of this study was to assess the difference in explained variance of Health-Related Quality of Life (HRQoL) between comorbidity, sociodemographic characteristics and cancer characteristics. This association was assessed among thyroid cancer, colorectal cancer, and (non-)Hodgkin’s lymphoma patients.Data from three large population-based surveys on survivors of thyroid cancer, colorectal cancer, and (non-)Hodgkin’s lymphoma were used. Cancer-specific HRQoL was assessed with the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Core 30 (QLQ-C30) of which physical function, emotional function, fatigue, and pain were included in the analyses. Comorbidity was assessed using the Self-reported Comorbidity Questionnaire. The association between comorbidity and HRQoL was assessed with multivariate linear regression models. Semi-partial R (2) was reported to assess the amount of variance in HRQoL explained by comorbidity in comparison with sociodemographic and cancer characteristics.In total, 3,792 cancer survivors were included in this analysis. The variance in HRQoL subscales explained by comorbidity was higher compared with sociodemographic and cancer characteristics for physical function (11-17 vs. 2-4 and 1-2 %, respectively) and emotional function (7-17 vs. 1-3 and 1-3 %, respectively), regardless of cancer type. In addition, comorbidity explained 7-20 and 11-13 % of the variance in pain and fatigue, respectively, compared to 0-4 % for both sociodemographic and cancer characteristics. Osteoarthritis and back pain were strongly associated with physical function and pain, while depression was strongly associated with emotional function. Depression and back pain were strongly associated with fatigue.This study showed that comorbidity explained more variance in physical and emotional function, pain, and fatigue in comparison with sociodemographic and cancer characteristics in cancer survivors, regardless of cancer type. Our findings emphasize the importance of adjusting for the presence of comorbid diseases when assessing HRQoL in cancer survivors.Cancer survivors suffering from comorbid diseases experience lower levels of health-related quality of life. Clinicians should become more aware of the impact of comorbidity on HRQoL and provide necessary psychological support to assist self-management of comorbid diseases. HubMed – depression

NATURAL DEPRESSION TREATMENT 40 Day Natural Depression Treatment Plan which teaches you how to fight the blues naturally with diet, supplements, herbs…